X T L Biopharmaceuticals reported $-47K in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Bioline Rx USD 19.53M 537K Sep/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025
X T L Biopharmaceuticals USD -47K 5.48M Jun/2025